Profitability
Weight: 25%
B+
76
- 5yr Avg ROIC 12.1%
- Operating Margin Trend +1.36 pp/yr
AMPH
Amphastar Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
A-
80
- 5yr Avg ROE 17.4%
- 5yr Share-Count CAGR -0.4%
Growth Quality
Weight: 25%
A
92
- 5yr Revenue CAGR 15.5%
- 5yr EPS CAGR 134.6%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
A
93
- 5yr FCF Margin 18.4%
- 5yr FCF/NI Conversion 1.04x
Balance Sheet
Weight: 10%
B-
68
- Net Debt / EBITDA 1.76x
- Interest Coverage (EBIT/Int) 5.85x
- Altman Z-Score 2.49
Stability
Weight: 5%
D+
43
- EPS Volatility (σ/μ) 0.83
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 6
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 1 new buy; 2 added.
- Holders
- 3 +2
- Avg Δ position
- +33.3%
- New buys
- 1
- Full exits
- 0
- Wood new
- Cooperman increased +33%
- Greenblatt increased